vs
Side-by-side financial comparison of Hippo Holdings Inc. (HIPO) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $120.4M, roughly 1.4× Hippo Holdings Inc.). Hippo Holdings Inc. runs the higher net margin — 5.0% vs -82.0%, a 86.9% gap on every dollar of revenue. On growth, Hippo Holdings Inc. posted the faster year-over-year revenue change (18.2% vs -22.7%). Hippo Holdings Inc. produced more free cash flow last quarter ($9.1M vs $-36.6M). Over the past eight quarters, Hippo Holdings Inc.'s revenue compounded faster (18.9% CAGR vs -11.5%).
Hippo Valley Estate is a sugar estate found near the town of Chiredzi in Chiredzi District of southeastern Zimbabwe, on the Runde River near the border with Mozambique.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
HIPO vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $120.4M | $164.7M |
| Net Profit | $6.0M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 5.6% | -43.3% |
| Net Margin | 5.0% | -82.0% |
| Revenue YoY | 18.2% | -22.7% |
| Net Profit YoY | -86.4% | -104.8% |
| EPS (diluted) | $0.31 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $120.4M | $164.7M | ||
| Q3 25 | $120.6M | $211.0M | ||
| Q2 25 | $117.3M | $178.9M | ||
| Q1 25 | $110.3M | $1.2B | ||
| Q4 24 | $101.9M | $213.2M | ||
| Q3 24 | $95.5M | $196.8M | ||
| Q2 24 | $89.6M | $186.7M | ||
| Q1 24 | $85.1M | $210.1M |
| Q4 25 | $6.0M | $-135.0M | ||
| Q3 25 | $98.1M | $15.9M | ||
| Q2 25 | $1.3M | $-64.8M | ||
| Q1 25 | $-47.7M | $866.6M | ||
| Q4 24 | $44.2M | $-65.9M | ||
| Q3 24 | $-8.5M | $-106.7M | ||
| Q2 24 | $-40.5M | $-99.2M | ||
| Q1 24 | $-35.7M | $-91.6M |
| Q4 25 | 5.6% | -43.3% | ||
| Q3 25 | 81.3% | 1.4% | ||
| Q2 25 | 3.4% | -19.5% | ||
| Q1 25 | -41.3% | 82.5% | ||
| Q4 24 | 46.3% | -76.2% | ||
| Q3 24 | -5.4% | -27.7% | ||
| Q2 24 | -40.7% | -21.5% | ||
| Q1 24 | -38.7% | -21.6% |
| Q4 25 | 5.0% | -82.0% | ||
| Q3 25 | 81.3% | 7.5% | ||
| Q2 25 | 1.1% | -36.3% | ||
| Q1 25 | -43.2% | 73.7% | ||
| Q4 24 | 43.4% | -30.9% | ||
| Q3 24 | -8.9% | -54.2% | ||
| Q2 24 | -45.2% | -53.1% | ||
| Q1 24 | -42.0% | -43.6% |
| Q4 25 | $0.31 | $-1.63 | ||
| Q3 25 | $3.77 | $0.20 | ||
| Q2 25 | $0.05 | $-0.83 | ||
| Q1 25 | $-1.91 | $10.04 | ||
| Q4 24 | $1.81 | $-0.85 | ||
| Q3 24 | $-0.34 | $-1.39 | ||
| Q2 24 | $-1.64 | $-1.29 | ||
| Q1 24 | $-1.47 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $218.3M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $436.1M | $-205.3M |
| Total Assets | $1.9B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $218.3M | $1.9B | ||
| Q3 25 | $247.7M | $1.7B | ||
| Q2 25 | $198.9M | $2.0B | ||
| Q1 25 | $140.9M | $2.0B | ||
| Q4 24 | $197.6M | $1.1B | ||
| Q3 24 | $191.2M | $1.0B | ||
| Q2 24 | $175.9M | $1.1B | ||
| Q1 24 | $223.4M | $884.8M |
| Q4 25 | $436.1M | $-205.3M | ||
| Q3 25 | $421.5M | $-155.8M | ||
| Q2 25 | $332.5M | $-206.5M | ||
| Q1 25 | $322.8M | $-185.8M | ||
| Q4 24 | $362.1M | $-1.1B | ||
| Q3 24 | $326.4M | $-1.1B | ||
| Q2 24 | $322.6M | $-980.2M | ||
| Q1 24 | $351.2M | $-893.9M |
| Q4 25 | $1.9B | $2.9B | ||
| Q3 25 | $1.9B | $2.6B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.5B | $2.7B | ||
| Q4 24 | $1.5B | $1.7B | ||
| Q3 24 | $1.5B | $1.8B | ||
| Q2 24 | $1.5B | $1.9B | ||
| Q1 24 | $1.5B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.2M | $-34.3M |
| Free Cash FlowOCF − Capex | $9.1M | $-36.6M |
| FCF MarginFCF / Revenue | 7.6% | -22.3% |
| Capex IntensityCapex / Revenue | 0.1% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.8M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.2M | $-34.3M | ||
| Q3 25 | $16.9M | $-66.3M | ||
| Q2 25 | $24.7M | $-58.3M | ||
| Q1 25 | $-35.6M | $870.1M | ||
| Q4 24 | $47.5M | $-30.0M | ||
| Q3 24 | $46.8M | $-77.0M | ||
| Q2 24 | $-10.6M | $-71.5M | ||
| Q1 24 | $17.7M | $70.8M |
| Q4 25 | $9.1M | $-36.6M | ||
| Q3 25 | $16.8M | $-69.7M | ||
| Q2 25 | $24.6M | $-59.6M | ||
| Q1 25 | $-35.7M | $868.4M | ||
| Q4 24 | $47.2M | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | $-10.7M | $-78.8M | ||
| Q1 24 | $17.6M | $61.2M |
| Q4 25 | 7.6% | -22.3% | ||
| Q3 25 | 13.9% | -33.1% | ||
| Q2 25 | 21.0% | -33.3% | ||
| Q1 25 | -32.4% | 73.8% | ||
| Q4 24 | 46.3% | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | -11.9% | -42.2% | ||
| Q1 24 | 20.7% | 29.1% |
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.3% | 1.8% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.1% | 4.0% | ||
| Q1 24 | 0.1% | 4.6% |
| Q4 25 | 1.53× | — | ||
| Q3 25 | 0.17× | -4.17× | ||
| Q2 25 | 19.00× | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
